• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Jobs
  • Events

Femtech Trendwatch: Investment Round-up October, Male Contraceptives on the Rise & The Hims Story

By Femtech Insider Trend Watch, Uncategorized November 1, 2021
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Gynecological Health, Investment, Medical Device, News, Uncategorized June 1, 2021
Ark Surgical Raises $2.1M for its LapBox Tissue Containment System for Laparoscopic GYN Surgery
Access, Biotech, News, Pharma, Uncategorized July 6, 2021
Medicines360, a Global Nonprofit Women’s Health Pharmaceutical Organization, Appoints Dr. Tina Raine-Bennett as Chief Executive Officer
Recent Posts
  • DKSH To Acquire Oral Contraceptive Brand Meliane From Bayer
  • Astrin Biosciences Study Validates Blood Test For Early-Stage Breast Cancer Detection
  • PMOS Linked To Increased Cardiovascular Disease Risk, Study Finds
  • Kompass Diagnostics Scales Rapid Finger-Prick Hormone Testing
  • Kāhu SiliconBio Secures £1.2M to Advance Continuous Hormone Monitoring

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.